Market Overview:

Global Drug Delivery Devices Market size accrued earnings worth approximately USD 1496 Million in 2023 and is predicted to gain revenue of about USD 2672.67 Million by 2032, is set to record a CAGR of nearly 7% over the period from 2024 to 2032.

Most of the pharmaceutical companies and governments are currently working to provide effective medical care to the patients suffering from COVID-19. In such a scenario, Drug Delivery Technologies will play an essential role. For instance, vaccination programs at the mass level are being initiated worldwide to inject immunity against the SARS-CoV-2 virus in human beings. But still, many companies are working to develop more efficient ways of delivering COVID-19 therapeutics to patients, including developing Nasal Drug Delivery systems and investing heavily in them, which is likely to have a significant impact on the Drug Delivery Market.

In this regard, an important development by Glenmark Pharmaceuticals Limited in India has been seen recently, that is, its launch of the nitric oxide nasal spray known as FabiSpray. It was aimed at adult patients with COVID-19 who have a high risk of progression of the disease in February 2022. Currently, use of drug delivery devices for treating COVID-19 is slowing down, and even though COVID-19 had drastically impacted the market, the overall Drug Delivery Devices Market is to increase steadily across the forecasted period. One major factor fuelling the market of Drug Delivery Technologies is due to the fast-paced growth rate in chronic disease incidence, technology enhancements, and further developments in Biologics. As Drug Delivery Devices help deliver medications beneficial for the targeted population to recover faster, there has been a growing adoption and inclination toward advanced Targeted Drug Delivery technologies, thus bolstering the Targeted Drug Delivery Market. Additionally, the rising number of cancers, respiratory disease, and diabetic patients worldwide may promote the adoption of drug delivery devices, including Controlled Release Drug Delivery systems, and drive the overall market.

According to the International Agency for Research on Cancer 2020, it is reported that globally, the lifetime risk of developing cancer is for 1 in 5 people, and 1 in 8 men and 1 in 11 women die. For women, common cancers include breast, colorectal, lung, cervical, and thyroid cancers. In contrast, lung and prostate cancer are the most common cancers for men, comprising nearly one-third of all male cancers. This increasing burden of cancer increases the adoption of Drug Delivery Devices, which will contribute significantly to the growth of the Drug Delivery Devices Market over the studied forecast period. Furthermore, the article published by Frontiers in July 2020 mentioned that it is necessary to develop appropriate delivery systems and complete therapy strategies according to the nature of drugs and diabetes mellitus. According to the source, Drug Delivery Devices, including advanced Insulin Delivery Devices, may have been potentially useful in many respects of the treatment of diabetes, such as improving the stability of drugs; offering more biological barriers different from in vivo to increase bioavailability; and acting as an intelligent, automated system for mimicking endogenous insulin delivery and preventing risk of hypoglycemia.

These are diabetes treatment advantages devices. Hence, the growing demand for new Drug Delivery Devices is going to propel the growth of the market under study. Technological advancements in drug delivery devices are going to make them more patient-friendly, accessible, and accurate. In line with this, players invest more in research and development and continuously innovate new technologies and advanced drug delivery devices. Phillips-Medisize introduced its Aria Smart Autoinjector platform in May 2021, which unlocks innovation, differentiation, and sustainability in the digital Autoinjector Market. The device includes advanced technologies, such as a modular Drug Delivery Technology platform, supporting a range of drug formulations and viscosities, with built-in Bluetooth that allows for connectivity to smartphones, tablets, and mobile apps.

Besides this, Roche also designed a Port Delivery System with ranibizumab known as PDS that is essentially a Drug Delivery Implant as an Implantable Drug Delivery system. PDS freed wet age-related macular degeneration patients from regular eye injections, for which this drug delivery implant has received priority review by the FDA. It is estimated that such an active participation by the leading market players is expected to bring significant influence into the growth of the Drug Delivery Technology Market. Consequently, all of these above-mentioned factors will fuel the size of the drug delivery market through the forecasted period. Still, the chance of a needle stick injury can inhibit market growth over the given forecasting period.

Market Drivers

Growing Demand for Self-Administration & Home Healthcare

The wearable and auto-injector devices revolutionize drug administration since they offer advantages in the realm of improving patients' convenience and adherence with care and improving total healthcare outcomes in general. Due to self-administration, a lot of constant hospital visits could be eliminated through these drugs with chronic diseases that include diabetes and rheumatoid arthritis among other diseases such as multiple sclerosis. Wearable drug delivery systems include insulin pumps and patch-based infusion devices, where the drug release is continuous or on-demand to ensure precise dosing and reduce side effects. Auto-injectors are easy to use; patients can easily administer medications without pain, sometimes with just a single push of a button. The integration of smart technology into these devices enhances patient engagement by providing reminders, tracking of dosage, and real-time health monitoring. Wearable and auto-injector technologies are the advancing technologies because the demand for patient-centric drug delivery is continually increasing, bringing better disease management, improved quality of life, and reduced costs for healthcare providers.

Market Opportunities

Expansion of Digital & Connected Drug Delivery Devices

With IoT and AI integrated into smart drug delivery devices, patient adherence and health monitoring are enhanced through real-time data and personalized insights. Such devices include smart inhalers, insulin pumps, and connected auto-injectors, which track the use of medications, remind patients, and thus avoid missed doses, therefore improving the outcomes of the treatment. IoT connectivity also allows interaction between devices, healthcare providers, and mobile applications to monitor the adherence of patients remotely while early identification of health issues is provided. In addition, the systems are built further by AI-based analytics that develops patterns in medication use, predicts a risk of nonadherence with individualized interventions. For chronic diseases such as diabetes or asthma, smart drug delivery devices can provide precise dosing with adaptive adjustment based on real-time physiological data. The new era of digital healthcare brought IoT and AI into drug delivery systems, which will help engage the patient, optimize treatment efficacy, reduce hospital readmission rates, and ultimately improve the efficiency of delivery in healthcare.

Market Restraining Factors

High Development & Manufacturing Costs

Advanced drug delivery systems require huge investment in research and development as designing and manufacturing the device, ensuring precision, safety, and efficacy is highly complex. Interdisciplinary expertise and state-of-the-art technology and testing are necessary to develop new systems such as targeted drug delivery platforms, nano-based systems, and smart devices. They demand high regulatory standards, meaning very extensive clinical trials, biocompatibility studies, and safety evaluation to ensure performance without causing harmful effects. Importantly, more R&D will be required in the following fields: overcoming difficulties such as mechanisms for controlled release, miniaturization of the device, and patient-centric design to improve usability and compliance. Such high development costs combined with the frequency at which such technologies face reinvention for changing medical needs is a factor that greatly contributes to R&D investments. The investment costs incurred in this research are too high; however, they advance drug delivery solutions and improve patient outcomes and derive market competitiveness.

Segmentation Analysis

The market scope is segmented because of by Device Type, by Route of Administration, by Application by End-User, by region.

• By Device Type

Based on the Device Type of the market is segmented into Injectable Devices, Implantable Devices, Inhalation Devices, Transdermal Devices, Wearable Devices.

The Injectable Devices segment leads the market in drug delivery devices, because of high demand and utility in the accurate delivery of drugs, especially in chronic diseases. Examples include auto-injectors and insulin pumps, which are used in managing diabetes and autoimmune diseases, thereby providing the patient with the self-administration option. Implantable devices, including contraceptive implants and drug-eluting stents, will allow drugs to be released continually at the exact site of the action, without the need to inject them in the body to achieve a greater therapeutic effect as frequently.

The inhalation type of devices - metered dose inhalers or MDIs-nebulizers used for respiratory-related disorders like asthma and chronic obstructive pulmonary diseases (COPD) would deliver medicine through the lungs where it would soothe the suffering patient immediately. Transdermal Devices, like nicotine patches and hormone replacement therapy patches, allow drug absorption through the skin while also allowing steady controlled drug release over time. Wearable devices, like insulin pumps and continuous drug infusion devices, have popularized the easy handling of chronic conditions, remote monitoring, and continuous delivery of medication improving patient compliance as well as comfort levels. With growing consumer demand for precisely delivered and easily administered therapies, injective devices are popular in the market.

• By Route of Administration

Based on the Route of Administration of the market is segmented into Oral Drug Delivery, Parenteral Drug Delivery, Topical Drug Delivery, Pulmonary Drug Delivery.

The Oral Drug Delivery dominated the global market, due to convenience, ease of use, and cost-effectiveness. Most common forms include tablets, capsules, and oral dissolving films. Some examples include tablets paracetamol designed to relieve pain. This system is highly sought for use with chronic diseases, considering prolonged adherence to medication is often required. Parenteral drug delivery is essential in application that needs rapid absorption of a drug, or when some drugs need controlled accurate delivery. Its applications will include insulin injections in the management of diabetes.

Topical drug delivery involves putting the drug in the place of action on the skin to result in localized or systemic effects. Some examples include hydrocortisone creams for skin conditions or nicotine patches for smoking cessation providing controlled release over time. Pulmonary Drug Delivery is directed to the lungs that would provide immediate absorption when dealing with respiratory conditions. MDIs and nebulizers play critical roles in asthma and COPD management since the medication is directly directed to the respiratory system for quicker action. Other than oral drug delivery, which remains the most prevalent, other routes of delivery satisfy specific therapeutic demands, making the treatment options varied for different diseases.

• Regional Snapshots

By region, Insights into the markets in North America, Europe, Asia-Pacific, Latin America and MEA are provided by the study. North America holds the greatest share due to its well-developed healthcare infrastructure, increased prevalence of chronic diseases, and strong adoption of innovative drug delivery technologies. New devices quickly gain approval due to the mature pharmaceutical sector and support from regulatory organizations such as the FDA. The injectable devices market includes auto-injectors and insulin pumps which are in a high demand by the increasing number of patients diagnosed with diabetes and autoimmune conditions. In addition to this, home healthcare solution and connected devices integrated with IoT and AI have further uplifted the market growth in North America. The drug delivery devices market has gained robust success in Europe due to the aging population in that region, health expenditure increase. For countries, such as Germany, UK and France, respiratory diseases in general, the primary requirements were witnessed for respiratory products like asthma, COPD including wearable, but also to inhalation-based device. With increasing biologics treatment due to diseases related with cancer as well as immune, followed with diabetes, advancement regarding injectable or implantable was seen under advanced drug delivery devices.

With easy access to healthcare, high disposable incomes, and a larger number of patients in countries like China and India, the Asia-Pacific market is a growth driver. With growing demand in emerging economies for investments in healthcare infrastructures, especially for low-cost drug delivery systems like oral and parenteral drug systems, the growth of the Asia-Pacific market is a threat to many bigger players. More importantly, the steadily rising growth trend of chronic and lifestyle-related disorders like diabetes and hypertension will take drug delivery technologies further.

Market of Latin America and Middle East & Africa are progressing with improving the healthcare systems in their countries and due to higher awareness towards delivery drug innovation among patients. Some of the Government also encourage them towards proper managing of chronic disease, thereby growth is also registered here, since adoption is moving slowly. Examples can be witnessed in the South African market where health accessibility improved; Brazil - people start showing more demand toward the cheaper availability of the delivery devices of drug.

Summarizing, the regional dynamics of drug delivery devices market vary as vastly as the needs for healthcare, regulatory landscapes, and innovation levels, which has North America on the vanguard of technology, while the Asia-Pacific has potential for high growth.

List of Companies Profiled

• Biocorp
• Becton, Dickinson and Company
• West Pharmaceutical Services Inc.
• Elcam Medical
• Holozymes Inc. (Antares Pharma Inc.).

Report Coverage

The report will cover the qualitative and quantitative data on the Global Drug Delivery Devices Market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.

Report Scope and Segmentations

Regional Snapshots:

North America accounted for the highest market share in 2023, with a share of 32.39%. Drug supply devices are becoming more and more popular, which is explained by the presence of big players in the area. Further projected to support market expansion in the region is growing awareness of the benefits of medication delivery devices throughout the region. Further anticipated to support market expansion is the rising product approval rates in nations like the United States. Vertiva, an adaptable medication distribution platform ideal for a broad range of medicines and high approach volumes, was introduced by Stevanato Group in June 2023.

The Europe area is predicted to expand at a modest CAGR and held a sizable proportion in 2023. For the main market participants in the area, developed economies and advantageous regulatory frameworks are among the main elements offering enormous prospects. Due to the high pace of economic growth in the region, Asia Pacific is anticipated to increase at the highest rate during the projection period. Adoption of drug supply devices by different end-users is also being facilitated by a sizable patient pool in nations like China, India, and Japan. Furthermore, many kinds of medication delivery equipment are used in Japan to deliver particular kinds of medications.

Drug Delivery Devices Market Report is also available for below Regions and Country Please Ask for that

North America

• U.S.
• Canada

Europe

• Switzerland
• Belgium
• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Rest of Europe

Asia-Pacific

• India
• Australia
• Philippines
• Singapore
• South Korea
• Japan
• China
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Argentina
• Peru
• Colombia
• Brazil
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Points Covered in the Report

• The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
• The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 5 years data history and forecast.
• The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
• Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.
• The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Questions

• How much the global Drug Delivery Devices Market valued?
• Which region has the largest share in 2024 for the global Drug Delivery Devices Market?
• What are the driving factors for the market?
• Which is the leading segment in the global market?
• What are the major players in the market?

Research Scope of Drug Delivery Devices Market

• Historic year: 2019- 2022
• Base year: 2023
• Forecast: 2024 to 2032
• Representation of Market revenue in USD Billion

Drug Delivery Devices Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends: